CorMedix Inc (CRMD) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.35
• Market Cap: $575.95M
• P/E Ratio: 3.31
• EPS: $2.21
• 52-Week High: $17.43
• 52-Week Low: $5.60

Market Sentiment

CorMedix Inc currently has a Neutral sentiment score of 0.02.

About CorMedix Inc

CorMedix Inc. is a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, specializing in the development and commercialization of innovative therapies for infectious and inflammatory diseases. The company is committed to addressing critical unmet medical needs, particularly in infection control and inflammatory conditions. With a robust pipeline of products aimed at improving patient outcomes, CorMedix is strategically positioned to impact the global healthcare landscape si...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for CorMedix Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CRMD pay dividends?

CorMedix Inc (CRMD) does not currently pay a regular dividend.

What is CRMD's P/E ratio?

CorMedix Inc has a price-to-earnings (P/E) ratio of 3.31.

What is CRMD's market cap?

CorMedix Inc (CRMD) has a market capitalization of $575.95M with a current stock price of $7.35.